Anthony Sun (Zentalis)
Flush with $165M IPO cash, Zentalis entices Tybourne, OrbiMed to fund a $20M China joint venture
Weeks after jumping into the public eye with an upsized $165 million IPO ($190 million if you count the overallotment), setting an upbeat tone …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
